2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies
Key Takeaways
Hypertension is formally diagnosed when clinic blood pressure is ≥140/90 mmHg and confirmed with daytime ambulatory (ABPM) or home (HBPM) monitoring showing an average ≥135/85 mmHg.
Pharmacological treatment follows the NICE step-wise pathway: Step 1 initiates an ACEi/ARB in patients aged <55 years who are not of Black African or African-Caribbean family origin (or who have type 2 diabetes), versus a CCB (amlodipine) in patients aged ≥55 years or of Black African/African-Caribbean origin without diabetes; Step 2 combines A + C or A + D; Step 3 combines A + C + D.
Resistant hypertension (Step 4) requires checking serum potassium: add low-dose spironolactone if K+ ≤4.5 mmol/L, or an alpha-blocker (doxazosin) or beta-blocker if K+ >4.5 mmol/L.
Valvular heart disease is distinguished by classic auscultation: aortic stenosis produces a harsh crescendo-decrescendo ejection systolic murmur radiating to the carotids with a slow-rising pulse; aortic regurgitation features an early diastolic murmur with a collapsing water-hammer pulse; mitral regurgitation exhibits a blowing pansystolic murmur radiating to the axilla.
Aortic dissection is classified by the Stanford system: Type A involves the ascending aorta and represents an emergency cardiothoracic surgical catastrophe; uncomplicated Type B involves the descending aorta and is managed medically with tight blood pressure and heart rate control (target systolic BP 100–120 mmHg) using IV labetalol.
Hypertension, Valvular Heart Disease & Aortic Emergencies
Cardiovascular and vascular disorders comprise a massive proportion of clinical practice in the UK. This section reviews three cornerstone areas: the formal staging and stepped pharmacological management of systemic hypertension under NICE guidelines, the diagnostic bedside recognition and surgical thresholds for valvular heart disease, and the acute emergency management of thoracic aortic dissection and abdominal aortic aneurysms.
1. Systemic Hypertension: Diagnosis & Staging
Hypertension is the single greatest preventable cause of cardiovascular disease, stroke, and vascular dementia globally. In England, over 14 million adults have hypertension, with half remaining undiagnosed or inadequately controlled.
Diagnostic Protocol & Blood Pressure Staging
A diagnosis of hypertension must never be established on a single opportunistic clinic reading unless severe Stage 3 hypertension is present. If clinic blood pressure is between 140/90 mmHg and 179/119 mmHg, clinicians must offer Ambulatory Blood Pressure Monitoring (ABPM) (or Home Blood Pressure Monitoring [HBPM] if ABPM is not tolerated) to confirm the diagnosis and eliminate the "white-coat effect".
- Stage 1 Hypertension:
- Clinic blood pressure: 140/90 to 159/99 mmHg AND
- Daytime average ABPM / HBPM: 135/85 to 149/94 mmHg.
- Stage 2 Hypertension:
- Clinic blood pressure: 160/100 to 179/119 mmHg AND
- Daytime average ABPM / HBPM: ≥150/95 mmHg.
- Stage 3 (Severe) Hypertension:
- Clinic systolic BP ≥180 mmHg OR diastolic BP ≥120 mmHg.
- Immediate Action: Examine urgently for target organ damage: papilloedema or retinal haemorrhages on fundoscopy (accelerated/malignant hypertension), new chest pain, acute kidney injury, acute confusion/encephalopathy, or pulmonary oedema. If target organ damage is present, refer immediately for emergency same-day hospital admission for parenteral treatment (e.g. IV labetalol or nicardipine). If no target organ damage is present, conduct urgent investigations in primary care and initiate oral pharmacotherapy without waiting for ABPM confirmation.
Indications for Treatment
- Stage 2 & Stage 3: Initiate pharmacological treatment immediately, alongside lifestyle advice, regardless of age or risk score.
- Stage 1: Offer pharmacological antihypertensive treatment in adults aged <80 years who have one or more of: target organ damage (LVH on ECG, microalbuminuria, retinopathy), established cardiovascular disease, renal impairment (CKD), type 2 diabetes, or an estimated 10-year cardiovascular risk score QRISK3 ≥10%.
- Blood Pressure Targets:
- Adults aged <80 years: Clinic BP <140/90 mmHg (daytime ABPM/HBPM <135/85 mmHg).
- Adults aged ≥80 years: Clinic BP <150/90 mmHg (daytime ABPM/HBPM <145/85 mmHg).
NICE Stepped Pharmacological Algorithm
NICE guidelines establish a clear, evidence-based ladder for drug selection:
| Treatment Step | Patient Category / Clinical Group | First-Line Drug Class & Exemplar Agents | Clinical Rationale & Important Caveats |
|---|---|---|---|
| Step 1 | Age <55 years AND NOT of Black African or African-Caribbean family origin | ACE Inhibitor (A) (e.g. Ramipril 2.5–10 mg OD) OR ARB (A) (e.g. Candesartan 8–32 mg OD, Losartan) | Younger non-Black patients have renin-driven hypertension. If ACEi causes dry intractable cough (due to bradykinin accumulation), switch to an ARB. |
| Step 1 | Age ≥55 years OR any age of Black African / African-Caribbean origin | Calcium Channel Blocker (CCB) (C) (e.g. Amlodipine 5–10 mg OD) | Older and Black patients have low-renin, salt-sensitive hypertension. If CCB causes severe peripheral ankle oedema or is not tolerated, substitute a thiazide-like diuretic (D) (Indapamide 1.5 mg MR or 2.5 mg OD). |
| Step 1 (Special) | Adults with Type 2 Diabetes (any age, any ethnicity) | ACE Inhibitor (A) OR ARB (A) | Renoprotective: reduces intraglomerular pressure and delays progression of diabetic nephropathy and proteinuria. |
| Step 2 | Inadequate control on Step 1 monotherapy | A + C (ACEi/ARB + CCB) OR A + D (ACEi/ARB + Thiazide-like diuretic) | Dual therapy combining complementary mechanisms. In patients of Black African/African-Caribbean descent, prefer an ARB over an ACE inhibitor due to significantly higher risks of fatal angioedema. |
| Step 3 | Inadequate control on Step 2 dual therapy | Triple Therapy: A + C + D; (ACEi/ARB + CCB + Indapamide) | Full triple combination covering RAAS inhibition, arterial vasodilation, and renal natriuresis. |
| Step 4 | Resistant Hypertension (uncontrolled on optimal tolerated doses of A + C + D) | Check adherence, exclude white-coat effect via ABPM, and check serum potassium:; • If K+ ≤4.5 mmol/L: Add low-dose Spironolactone (25 mg OD).; • If K+ >4.5 mmol/L: Add an Alpha-blocker (Doxazosin) OR Beta-blocker (Bisoprolol). | Spironolactone provides mineralocorticoid receptor blockade for covert hyperaldosteronism. Close U&Es monitoring is mandatory. If K+ >4.5 mmol/L, spironolactone risks life-threatening hyperkalaemia. |
2. Valvular Heart Disease
Bedside auscultation and clinical recognition of heart murmurs are high-yield competencies in medical examinations. Transthoracic echocardiography is the definitive diagnostic modality for all suspected valvular lesions.
Clinical Comparison of Major Valvular Conditions
| Valvular Lesion | Auscultation & Murmur Characteristics | Pulse Character & Blood Pressure | Classical Symptoms & Physical Signs | Definitive Indications for Surgical / Transcatheter Intervention |
|---|---|---|---|---|
| Aortic Stenosis (AS) | Ejection systolic murmur, harsh, crescendo-decrescendo; best heard at the right 2nd intercostal space; radiates to both carotid arteries; soft/absent S2; ejection click in bicuspid valves. | Slow-rising, low-amplitude pulse (pulsus parvus et tardus); narrow pulse pressure (e.g. 100/80 mmHg). | Classic Triad: Angina (5-yr survival 50%), Syncope on exertion (3-yr survival 50%), Dyspnoea / Heart failure (2-yr survival 50%). Heaving, non-displaced apex beat. | Symptomatic severe AS; or asymptomatic severe AS with LVEF <50%.; • SAVR (Surgical): Generally for younger patients at low surgical risk.; • TAVI (Transcatheter): Generally for older patients or those at intermediate/high surgical risk; the choice is a heart-team decision considering age, anatomy and comorbidity (NICE NG208). |
| Aortic Regurgitation (AR) | Early diastolic decrescendo murmur, high-pitched, blowing; best heard at left 3rd/4th intercostal space with patient leaning forward in end-expiration; Austin Flint murmur (mid-diastolic apical rumble). | Collapsing, 'water-hammer' pulse (large-volume, rapid upstroke and fall); wide pulse pressure (e.g. 160/50 mmHg). | Dyspnoea, orthopnoea, pounding heart sensations. Eponymous peripheral signs: Corrigan's pulse (visible carotid pulsations), Quincke's sign (nail bed capillary pulsations), de Musset's sign (head-nodding). Displaced, hyperdynamic apex beat. | Symptomatic severe AR; or asymptomatic severe AR with resting LVEF ≤50% or severe LV dilatation (end-diastolic diameter >65–70 mm). Valve replacement and aortic root repair. |
| Mitral Regurgitation (MR) | Pansystolic (holosystolic) murmur, blowing; best heard at the cardiac apex; radiates laterally to the left axilla; soft S1; prominent S3 gallop in severe volume overload. | Normal or brisk pulse; normal or slightly reduced blood pressure. | Exertional dyspnoea, orthopnoea, pulmonary oedema, fatigue. Apex beat is displaced inferolaterally, hyperdynamic, with a systolic thrill in severe cases. | Severe primary MR when symptomatic; or asymptomatic with LVEF ≤60% or LV end-systolic diameter ≥40 mm. Mitral valve repair is preferred over valve replacement; percutaneous edge-to-edge repair (MitraClip) for high surgical risk. |
| Mitral Stenosis (MS) | Low-pitched rumbling mid-diastolic murmur with presystolic accentuation (if in sinus rhythm); best heard at the apex with the bell in the left lateral decubitus position; preceded by an opening snap; loud S1. | Low-volume, normal pulse; risk of irregularly irregular pulse due to high incidence of atrial fibrillation. | Dyspnoea, haemoptysis (rupture of bronchial veins), pulmonary hypertension, fatigue. Malar flush (plum-coloured cheeks from reduced cardiac output and cutaneous vasoconstriction). Right ventricular heave. | Symptomatic moderate-to-severe MS (valve area ≤1.5 cm2). Percutaneous Mitral Balloon Valvuloplasty (PMBV) is first-line if leaflets are pliable and no left atrial thrombus exists; surgical valve replacement if heavily calcified. |
3. Aortic Emergencies
Acute Aortic Dissection
Acute aortic dissection arises when a breach in the intimal layer allows arterial blood to surge into the media under high hydraulic pressure, separating the intima from the adventitia and creating a false lumen propagating proximally or distally.
- Risk Factors: Long-standing uncontrolled systemic hypertension (75%), connective tissue disorders (Marfan syndrome, vascular Ehlers-Danlos, Loeys-Dietz), bicuspid aortic valve, aortic coarctation, pregnancy, and prior aortic surgery.
- Clinical Presentation:
- Sudden-onset, extraordinarily severe, sharp "tearing" or "ripping" retrosternal or interscapular back pain, reaching maximal intensity at inception.
- Pulse Deficits: Asymmetric blood pressure with >20 mmHg difference between the left and right arms, or absent peripheral pulses.
- Associated Manifestations: New murmur of aortic regurgitation (due to retrograde dissection disrupting the aortic root/leaflets), neurological deficits (stroke from carotid artery occlusion), acute coronary ischaemia (inferior STEMI from RCA ostium occlusion), or acute cardiac tamponade (Beck's triad: hypotension, muffled heart sounds, elevated JVP) from rupture into the pericardial sac.
- Diagnostic Investigation: CT Aortogram (computed tomography angiography of chest, abdomen, and pelvis) is the definitive, immediate gold-standard investigation in haemodynamically stable patients. If haemodynamically unstable, urgent bedside Transoesophageal Echocardiography (TOE) is indicated.
- Stanford Classification & Management:
- Stanford Type A (DeBakey I & II): Involves the ascending aorta (with or without arch/descending involvement). Represents a surgical catastrophe with a mortality rate of 1–2% per hour if untreated. Management: Immediate emergency cardiothoracic transfer for open surgical repair (synthetic graft replacement of the ascending aorta +/- aortic root/valve reconstruction).
- Stanford Type B (DeBakey III): Involves only the descending aorta distal to the origin of the left subclavian artery. Management: Primarily medical therapy in an intensive care or high-dependency environment: aggressive blood pressure and heart rate control using intravenous Labetalol infusion (or esmolol/metoprolol + sodium nitroprusside), targeting a systolic BP of 100–120 mmHg and heart rate of 60–80 bpm to reduce aortic wall shear stress (dP/dt). Thoracic Endovascular Aortic Repair (TEVAR) is reserved for complicated Type B dissections (rupture, persistent intractable pain, limb or visceral ischaemic malperfusion, rapid expansion).
Abdominal Aortic Aneurysm (AAA)
An abdominal aortic aneurysm is a permanent focal dilatation of the abdominal aorta exceeding 3.0 cm in diameter (normal adult diameter ~2.0 cm), typically infrarenal in location.
- NHS AAA Screening Programme: A single screening abdominal ultrasound scan is offered to all men in the UK during their 65th year.
- Surveillance & Intervention Thresholds:
- Normal (<3.0 cm): Discharged from screening programme.
- Small AAA (3.0–4.4 cm): Annual surveillance ultrasound.
- Medium AAA (4.5–5.4 cm): 3-monthly surveillance ultrasound.
- Large AAA (≥5.5 cm) OR expansion >1.0 cm per year: Immediate vascular referral for elective repair (Endovascular Aneurysm Repair [EVAR] or open surgical graft repair).
- Ruptured AAA: Presents with the classic clinical triad: (1) sudden-onset severe abdominal, flank, or back pain; (2) a tender, expansile, pulsatile abdominal mass; and (3) haemodynamic shock/collapse. Emergency protocol dictates: immediate cross-match, permissive hypotension (target SBP 80–90 mmHg to avoid dislodging the retroperitoneal clot tamponade), and immediate transfer directly to the vascular operating theatre for emergency surgical or endovascular repair without delaying for CT imaging in unstable patients.
A 62-year-old man of Black African descent attends his general practice for a routine health check. He has no significant past medical history and takes no medications. On examination, his clinic blood pressure is 154/96 mmHg. A subsequent 24-hour ambulatory blood pressure monitoring (ABPM) study demonstrates a daytime average blood pressure of 146/92 mmHg. Urinalysis shows no proteinuria, serum creatinine and electrolytes are normal, and a 12-lead ECG is entirely unremarkable. His calculated QRISK3 cardiovascular risk score is 14%. In accordance with NICE guidelines, what is the most appropriate initial pharmacological antihypertensive therapy?
Ramipril 2.5 mg once daily
Amlodipine 5 mg once daily
Indapamide 2.5 mg once daily
Bisoprolol 2.5 mg once daily
A 74-year-old retired schoolteacher presents to his GP with a 4-month history of progressive shortness of breath when walking up hills and two recent episodes of lightheadedness and presyncope while hurrying to catch a bus. On examination, his blood pressure is 108/84 mmHg and his pulse is regular at 72 bpm with a slow upstroke and low amplitude. Cardiac auscultation reveals a harsh crescendo-decrescendo systolic murmur loudest at the second right intercostal space, which radiates clearly into the right and left carotid arteries. The second heart sound (S2) is soft and single. What is the single most definitive diagnostic investigation required to evaluate the severity of the suspected condition?
Transthoracic echocardiography
24-hour ambulatory Holter ECG monitoring
Exercise treadmill stress testing
High-resolution computed tomography coronary angiography
A 64-year-old man with a 15-year history of poorly controlled hypertension presents to the emergency department with sudden-onset, agonising chest pain that he describes as a 'tearing' sensation that radiates directly through to his interscapular back. On examination, he is pale and diaphoretic. His blood pressure is 194/108 mmHg in his right arm and 156/88 mmHg in his left arm, with equal, palpable femoral pulses. Heart auscultation reveals normal heart sounds with no murmurs, and his chest is clear. An emergency CT aortogram reveals an intimal flap originating 2 cm distal to the origin of the left subclavian artery and extending into the descending thoracic aorta, with no evidence of visceral malperfusion, aortic rupture, or ascending aorta involvement. What is the definitive initial medical management for this patient?
Emergency referral for open cardiothoracic sternotomy and aortic graft replacement
Intravenous hydralazine boluses targeting a systolic blood pressure below 140 mmHg
Intravenous thrombolysis with tenecteplase and therapeutic enoxaparin
IV labetalol targeting systolic BP 100–120 mmHg and heart rate 60–80 bpm
Sections you finish are checked off in the contents.